Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus.
Sebastian BrueraXiudong LeiHui ZhaoRebecca GraingerMariana Chavez-MacGregorSharon H GiordanoMaria E Suarez-AlmazorPublished in: Lupus science & medicine (2023)
Patients with SLE had increased risk of severe COVID-19-related outcomes compared with matched controls. Patients with severe SLE disease activity or prior use of corticosteroids experienced worse outcomes.
Keyphrases
- systemic lupus erythematosus
- disease activity
- coronavirus disease
- rheumatoid arthritis
- rheumatoid arthritis patients
- sars cov
- ankylosing spondylitis
- early onset
- juvenile idiopathic arthritis
- respiratory syndrome coronavirus
- type diabetes
- drug induced
- metabolic syndrome
- risk assessment
- coronary artery disease
- cardiovascular events
- weight loss